These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 5134836)

  • 21. Inhibition of the tissue factor-factor VII complex: involvement of factor Xa and lipoproteins.
    Hubbard AR; Jennings CA
    Thromb Res; 1987 May; 46(4):527-37. PubMed ID: 3617011
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A sensitive assay of extrinsic coagulation pathway inhibitor (EPI) in plasma and plasma fractions.
    Sandset PM; Abildgaard U; Pettersen M
    Thromb Res; 1987 Aug; 47(4):389-400. PubMed ID: 3499007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. cDNA sequence of rabbit tissue factor pathway inhibitor.
    Warn-Cramer BJ; Broze GJ; Komives EA
    Nucleic Acids Res; 1992 Jul; 20(13):3548. PubMed ID: 1630940
    [No Abstract]   [Full Text] [Related]  

  • 24. THE EFFECT OF LANTHANIDES AND ACTINIDES ON BLOOD COAGULATION. I. EVIDENCE FOR THE PROPERTIES OF A NEW SERUM THROMBOPLASTIC FACTOR.
    COLMAN R; ALEXANDER B
    J Clin Invest; 1964 Apr; 43(4):705-19. PubMed ID: 14153486
    [No Abstract]   [Full Text] [Related]  

  • 25. A PstI RFLP of the LACI gene.
    van der Logt CP; Reitsma PH; Bertina RM
    Nucleic Acids Res; 1990 Oct; 18(19):5920. PubMed ID: 1977143
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition of activated coagulation factor VII by normal human plasma.
    Dahl PE; Abildgaard U; Larsen ML; Tjensvoll L
    Thromb Haemost; 1982 Dec; 48(3):253-6. PubMed ID: 7164015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue factor pathway inhibitor revisited.
    Hjort PF; Sandset PM; Abildgaard U; Rao LV; Mast A; Ott I; Bajaj SP
    J Thromb Haemost; 2004 Dec; 2(12):2241-9. PubMed ID: 15613032
    [No Abstract]   [Full Text] [Related]  

  • 28. Release of extrinsic pathway inhibitor after heparin injection: increased response in cancer patients.
    Lindahl AK; Abildgaard U; Stokke G
    Thromb Res; 1990 Aug; 59(3):651-6. PubMed ID: 2237832
    [No Abstract]   [Full Text] [Related]  

  • 29. Synergism between full length TFPI and heparin: evidence for TFPI as an important factor for the antithrombotic activity of heparin.
    Valentin S; Ostergaard P; Kristensen H; Nordfang O
    Blood Coagul Fibrinolysis; 1992 Apr; 3(2):221-2. PubMed ID: 1318759
    [No Abstract]   [Full Text] [Related]  

  • 30. Extrinsic coagulation pathway inhibitor and heparin cofactor II during normal and hypertensive pregnancy.
    Sandset PM; Hellgren M; Uvebrandt M; Bergström H
    Thromb Res; 1989 Sep; 55(5):665-70. PubMed ID: 2814949
    [No Abstract]   [Full Text] [Related]  

  • 31. High plasma levels of extrinsic pathway inhibitor and low levels of other coagulation inhibitors in advanced cancer.
    Lindahl AK; Sandset PM; Abildgaard U; Andersson TR; Harbitz TB
    Acta Chir Scand; 1989 Aug; 155(8):389-93. PubMed ID: 2596246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic fibrinolysis. What should follow?
    Stead NW
    Circulation; 1991 Aug; 84(2):948-50. PubMed ID: 1860243
    [No Abstract]   [Full Text] [Related]  

  • 33. [Vascular function tests for diagnosis of blood coagulation disorders].
    Maruyama I
    Nihon Naika Gakkai Zasshi; 1991 Jun; 80(6):839-43. PubMed ID: 1919197
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibitor of the factor VIIa-tissue factor complex is reduced in patients with disseminated intravascular coagulation but not in patients with severe hepatocellular disease.
    Bajaj MS; Rana SV; Wysolmerski RB; Bajaj SP
    J Clin Invest; 1987 Jun; 79(6):1874-8. PubMed ID: 3034984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extrinsic pathway inhibitor (EPI) released to the blood by heparin is a more powerful coagulation inhibitor than is recombinant EPI.
    Lindahl AK; Abildgaard U; Larsen ML; Staalesen R; Hammer AK; Sandset PM; Nordfang O; Beck TC
    Thromb Res; 1991 Jun; 62(6):607-14. PubMed ID: 1926055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intron-exon organization of the human gene coding for the lipoprotein-associated coagulation inhibitor: the factor Xa dependent inhibitor of the extrinsic pathway of coagulation.
    van der Logt CP; Reitsma PH; Bertina RM
    Biochemistry; 1991 Feb; 30(6):1571-7. PubMed ID: 1993173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Studies on the prothrombin complex, I. Behavior of prothrombin, factor VII, IX and X on barium sulfate].
    Voss D
    Hoppe Seylers Z Physiol Chem; 1967 Sep; 348(9):1163-71. PubMed ID: 4968304
    [No Abstract]   [Full Text] [Related]  

  • 38. Does nafamostat mesilate inhibit the tissue factor pathway?
    Matsuo T; Kario K; Matsuo M
    Thromb Res; 1994 Sep; 75(6):673-4. PubMed ID: 7831687
    [No Abstract]   [Full Text] [Related]  

  • 39. Barium sulphate adsorption and elution of the 'prothrombin complex' factors.
    Voss D
    Scand J Clin Lab Invest; 1965; 17():Suppl 84:119+. PubMed ID: 4955611
    [No Abstract]   [Full Text] [Related]  

  • 40. The adsorption of coagulation factors onto phospholipids. Its role in the reaction mechanism of blood coagulation.
    Hemker HC; Kahn MJ; Devilee PP
    Thromb Diath Haemorrh; 1970 Oct; 24(1):214-23. PubMed ID: 4320747
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.